View of Modulation of autophagy as a therapeutic target in the treatment of metabolic dysfunction-associated steatotic liver disease: evidence from pharmacological, nutritional, and bioactive compound interventions

Return to Article Details Modulation of autophagy as a therapeutic target in the treatment of metabolic dysfunction-associated steatotic liver disease: evidence from pharmacological, nutritional, and bioactive compound interventions Download Download PDF